高级搜索
杨明, 冯彦林, 冼伟均, 鲁胜男, 王颖, 李雯, 黄克敏. 18F-FDG PET/CT多参数及Deauville五分法在弥漫大B细胞淋巴瘤疗效评估和预后预测中的价值[J]. 肿瘤防治研究, 2020, 47(8): 611-616. DOI: 10.3971/j.issn.1000-8578.2020.20.0041
引用本文: 杨明, 冯彦林, 冼伟均, 鲁胜男, 王颖, 李雯, 黄克敏. 18F-FDG PET/CT多参数及Deauville五分法在弥漫大B细胞淋巴瘤疗效评估和预后预测中的价值[J]. 肿瘤防治研究, 2020, 47(8): 611-616. DOI: 10.3971/j.issn.1000-8578.2020.20.0041
shu
YANG Ming, FENG Yanlin, XIAN Weijun, LU Shengnan, WANG Ying, LI Wen, HUANG Kemin. Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 611-616. DOI: 10.3971/j.issn.1000-8578.2020.20.0041
Citation: YANG Ming, FENG Yanlin, XIAN Weijun, LU Shengnan, WANG Ying, LI Wen, HUANG Kemin. Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients[J]. Cancer Research on Prevention and Treatment, 2020, 47(8): 611-616. DOI: 10.3971/j.issn.1000-8578.2020.20.0041
shu

18F-FDG PET/CT多参数及Deauville五分法在弥漫大B细胞淋巴瘤疗效评估和预后预测中的价值

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients

    摘要
  • 摘要:
    目的 探讨最大标准化摄取值（SUVmax）、SUVmax下降值（ΔSUVmax）、肿瘤代谢体积（MTV）、BCL-2、BCL-6蛋白表达对弥漫大B细胞淋巴瘤（DLBCL）患者预后的预测价值。
    方法 回顾性分析55例DLBCL患者的18F-FDG PET/CT表现，应用18F-FDG PET/CT Deauville五分法（5-PS）评估中期化疗效果，应用卡方检验分析SUVmax、ΔSUVmax、MTV、BCL-2、BCL-6蛋白表达和疗效的相关性；用Kaplan-Meier生存分析和Cox回归法分析△SUVmax、Deauville标准、MTV、BCL-2、BCL-6蛋白对患者2年无疾病进展生存期（PFS）的预测价值。
    结果 SUVmax与中期疗效无明显相关性（P > 0.05）；ΔSUVmax、MTV、BCL-2、BCL-6和疗效显著相关（P=0.029, 0.005, 0.001, 0.014）；单因素和多因素分析ΔSUVmax < 10.6、MTV < 30.1 cm3、Deauville < 4分、BCL-6（-）各组2年PFS和ΔSUVmax≥10.6、MTV≥30.1 cm3、Deauville≥4分、BCL-6（+）各组比较差异均有统计学意义（P < 0.05），BCL-2组仅单因素分析2年PFS差异有统计学意义（P=0.039）。
    结论 ΔSUVmax、MTV和中期疗效呈负相关，BCL-2（-）、BCL-6（-）患者显示出好的疗效；ΔSUVmax、MTV、Deauville标准、BCL-6蛋白均是DLBCL患者2年PFS的独立影响因素。

     

    Abstract:
    Objective To analyze the prognostic value of SUVmax, ΔSUVmax, MTV and BCL-2 and BCL-6 expression on DLBCL patients.
    Methods We retrospectively analyzed the 18F-FDG PET/CT manifestation of 55 DLBLC patients, and evaluated the middle-stage chemotherapy effect with 5-PS by 18F-FDG PET/CT scan. Chi-square test was used for analysing the correlation of the chemotherapy efficacy with SUVmax, ΔSUVmax, MTV and the expression of BCL-2 and BCL-6. Kaplan-Meier analysis and Cox regression analysis were used for the predictive value of ΔSUVmax, MTV, Deauville score and the expression of BCL-2 and BCL-6 on the 2-years PFS of DLBCL patients.
    Results There was no correlation between SUVmax and the middle-stage chemotherapy effect (P > 0.05); ΔSUVmax, MTV and the expression of BCL-2 and BCL-6 were positively correlated with chemotherapy effect (P=0.029, 0.005, 0.001, 0.014). By univariate and multivariate analyses, there were statistical differences in 2-years PFS between ΔSUVmax < 10.6, MTV < 30.1 cm3, Deauville score < 4, BCL-6(-) groups and ΔSUVmax≥10.6, MTV≥30.1 cm3, Deauville score≥4, BCL-6(+) groups (P < 0.05). There was statistical difference in 2-years PFS of the patients with BCL-2 by univariate analysis (P=0.039).
    Conclusion There are negatively correlation between ΔSUVmax, MTV and the middle-stage chemotherapy effect. Patients with BCL2(-) and BCL-6(-) have good efficacy. ΔSUVmax, MTV, Deauville score and BCL-6 are independent prognostic factors for the 2-years PFS of DLBCL patients.

     

    • HTML全文
    • 参考文献(25)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回

This work is licensed under a Creative Commons Attribution 3.0 License.

邮件订阅 RSS
总访问量： 今日访问：